NexImmune, Inc. (OTCPK: NEXI)
Health Care · Biotechnology · US
$—
— today · — 1Y
NexImmune, Inc. (OTCPK: NEXI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $139.00 and employs 6 people.
trading between 0.00 and 2.17.
Tweenvest scores NexImmune, Inc. across four factors: quality 33/100, value 19/100. Its strongest factor is quality.
NEXI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $139.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -17.39
- Dividend yield
- —
- Beta (5Y)
- 3.61
- 52-week high
- $2.17
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.39M
- Employees
- 6
- Next earnings
- —
About NexImmune, Inc.
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company’s product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It also provides NEXI-004 which is in preclinical stage for EBV related diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
- ISIN
- US65344D2080
- Founded
- 2011
- Listed since
- Feb 12, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Regenicin, Inc.OTCPK: RGIN | $153.00 | $0.00 | — |
| Immage Biotherapeutics Corp.OTCPK: IMMG | $152.00 | $— | — |
| Poniard Pharmaceuticals, Inc.OTCPK: PARD | $150.00 | $— | — |
| CardioGenics Holdings IncOTCPK: CGNH | $143.00 | $— | — |
| PsyBio Therapeutics Corp.OTCPK: PSYB.F | $133.00 | $— | — |
| Marizyme, Inc.OTCPK: MRZM | $132.00 | $— | — |
| Lattice Biologics Ltd.OTCPK: LBLT.F | $128.00 | $— | — |
| Infinity Pharmaceuticals, Inc.OTCPK: INFI.Q | $91.00 | $0.00 | -99.00% |
Figures last refreshed Oct 4, 2026.